Spinal shot vs IV drip: which helps you recover faster from robotic surgery?
NCT ID NCT06349668
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial tests whether a single spinal injection of morphine and bupivacaine before robotic kidney or ureter surgery leads to better recovery than an intravenous lidocaine drip during surgery. About 220 adults scheduled for robotic upper urinary tract surgery will be randomly assigned to one of the two pain management methods. The main goal is to see if the spinal group reports less drop in wellbeing the day after surgery, measured by a standard recovery questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
spinal morphine with bupivacaine
What this could lead to
If spinal morphine works better, it could become a standard way to improve recovery and reduce pain after robotic kidney or ureter surgery.
What could go wrong
This is a mid-stage trial with 220 participants, so results may not apply to everyone. Spinal morphine can cause itching, low blood pressure, or heart issues during surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centrallasarettet Växjö
NOT_YET_RECRUITINGVaxjo, Sweden
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Länssjukhuset i Kalmar
RECRUITINGKalmar, Sweden
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Linköping
RECRUITINGLinköping, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••